CME Group (CME) Earns “Buy” Rating from Citigroup

CME Group (NASDAQ:CME)‘s stock had its “buy” rating reiterated by Citigroup in a note issued to investors on Monday, MarketBeat.com reports. They presently have a $172.00 price target on the financial services provider’s stock, up from their previous price target of $155.00. Citigroup’s price target indicates a potential upside of 12.09% from the stock’s current price.

Several other analysts have also recently commented on the company. Berenberg Bank began coverage on CME Group in a research report on Thursday. They issued a “hold” rating and a $170.00 target price on the stock. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Tuesday, January 9th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research report on Tuesday, January 2nd. Royal Bank of Canada raised their target price on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Finally, Barclays raised their target price on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $148.50.

CME Group (CME) traded down $1.71 on Monday, reaching $153.45. The company had a trading volume of 1,221,765 shares, compared to its average volume of 1,168,172. CME Group has a 12-month low of $114.82 and a 12-month high of $156.49. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. The firm has a market cap of $52,617.08, a PE ratio of 34.80, a P/E/G ratio of 2.09 and a beta of 0.72.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same period last year, the firm earned $1.05 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. equities analysts predict that CME Group will post 4.75 EPS for the current fiscal year.

In other news, insider Jack J. Tobin sold 2,325 shares of CME Group stock in a transaction on Monday, December 18th. The stock was sold at an average price of $152.28, for a total transaction of $354,051.00. Following the transaction, the insider now directly owns 17,574 shares in the company, valued at approximately $2,676,168.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO John W. Pietrowicz sold 5,175 shares of CME Group stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total value of $722,947.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 42,603 shares of company stock worth $6,250,726. 0.57% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of the company. Salem Investment Counselors Inc. boosted its stake in shares of CME Group by 6.5% during the 2nd quarter. Salem Investment Counselors Inc. now owns 1,678 shares of the financial services provider’s stock worth $210,000 after acquiring an additional 103 shares in the last quarter. People s United Financial Inc. boosted its stake in shares of CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares in the last quarter. First Allied Advisory Services Inc. boosted its stake in shares of CME Group by 5.1% during the 2nd quarter. First Allied Advisory Services Inc. now owns 2,896 shares of the financial services provider’s stock worth $381,000 after acquiring an additional 141 shares in the last quarter. Finally, Bluefin Trading LLC boosted its stake in shares of CME Group by 2.9% during the 2nd quarter. Bluefin Trading LLC now owns 7,128 shares of the financial services provider’s stock worth $893,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 82.91% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CME Group (CME) Earns “Buy” Rating from Citigroup” was originally published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/29/citigroup-raises-cme-group-cme-price-target-to-172-00.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply